Luciana Leite | Founder and Scientifica Advisor
BCGene

Luciana Leite, Founder and Scientifica Advisor, BCGene

Senior Researcher at the Vaccine Development Laboratory, Butantan Institute. She specializes in molecular biology applied to vaccine development, mainly using ​​recombinant BCG technology and has participated in several of the Brazilian genomic projects with over 150 papers published and several patents. The first product developed, a recombinant BCG strain for improved bladder cancer treatment has the Phase I clinical trial planned for mid 2026. She is currently moving forward with the development of a new recombinant BCG strain as an improved vaccine against tuberculosis for both humans and bovines. 

Appearances:



Day 2 - Wednesday 1st April @ 13:10

5-Minute Presentations - Innovator Showcase

1:10 Dr Julie Zhou, Head of Corporate Development, Delonix Bioworks

1:15 - “A First-in-Class Therapeutic Vaccine for Chronic Inflammation” Sean McLoughlin, CEO, Denteric 

1:20 - Dr Ivo Ploeman, Co-Founder & Co-CEO, Praetorian Bio

1:25 - 'Transforming Viral Immune Surveillance & Drug Discovery'Linda D. Chilin, MS, Associate Research Scientist, Athari Biosciences 

1:30  Asel Sartbaeva, CEO, Ensilitech 

1:35  Dr Robert Ernst, Founder & SAB Chair, TollereBio 

1:40  Patty Tawardos, CEO, Donor X 

1:45  Luciana Leite, Founder, BCGene 

1:50 Sarah-Meryll Buet, CEO, Alkion BioInnovations 

1:55 Gregory Smith, CSO & Co-Founder, Thyreos Vaccines

2:00 - "Building the Future of Bacterial Prevention: Advancing Phage Prophylaxis for Cholera" - Dr Minmin Yen, CEO & Co-Founder, PhagePro 

2:05 Professor Juliane Bubeck Wardenburg, Founder, Forward Defense LLC 

last published: 11/Mar/26 19:15 GMT

back to speakers